Will David Sinclair be regularly taking a SGLT2 inhibitor (canagliflozin, empagliflozin) by the end of 2025?
Mini
2
Ṁ202026
50%
chance
1D
1W
1M
ALL
Get Ṁ1,000 play money
Related questions
Related questions
What fraction of US adults will regularly take GLP-1 drugs in 2030?
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
58% chance
Will an oral insulin pill be publicly available before the end of 2025?
18% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
75% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
33% chance
Will Morgan Levine start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
54% chance
Will a senolytic drug be used clinically for any purpose by the end of 2028?
58% chance
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance